ScinoPharm Taiwan, Ltd.
Tainan, Taiwan scinopharm.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
ScinoPharm Taiwan, Ltd. develops and manufactures high-barrier APIs and drug products, with integrated CDMO and CMC services for global pharmaceutical clients. The company is headquartered in Tainan, Taiwan, and also operates API manufacturing facilities in Taiwan and Changshu, China.
Services
API development and manufacturing
Develops and manufactures high-potency APIs, including oncology, CNS, cardiovascular, orphan drug, small molecule, and peptide products.
Drug product development and manufacturing
Develops and manufactures injectable drug products, including sterile and high-potency injectables.
CDMO services
Provides end-to-end contract development and manufacturing from process development and clinical sample preparation to commercial-scale production.
CMC capabilities and support
Offers one-stop CMC solutions including technical guidance, regulatory support, market authorization application, and post-launch process improvement.
Contract analytical testing services
Provides cGMP-compliant analytical testing as part of its CDMO offering.
Capabilities
As they state on their website or in their listing.
- Assays and studies
- Peptides
- Small molecules
- Process development
- Analytical testing
- cGMP-compliant analytical testing
- Process hazard analysis
- Safety testing
- Toxicity prediction
- Scale and capacity
- 18 CGMP-compliant production lines
- Reactors ranging from 20 L to 10,000 L
- Batches from a few grams to metric ton scale
- Production capacity up to 200 kg per year
- Maximum capacity of 7,800 units per hour for 1 mL products
- Maximum batch size of approximately 19,000 units for 10R ISO vials
- Therapeutic areas
- Oncology
- Hematology
- Central nervous system disorders
- Metabolic diseases
- Cardiovascular
- Orphan diseases
- Scales
- Gram · Kilogram · Ton
Instruments and platforms
- Differential scanning calorimeters
- Reaction calorimeters
- Adiabatic calorimeters (PHI-TEC II)
- eQMS
- Derek Nexus
- Sarah Nexus for Windows
- 10 m2 freeze-dryer (lyophilizer)
Modalities and species
- Modalities
- Small molecule
- Peptide
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing compliance
GLPSelf-reported
Company
- Type
- CRDMO
- Founded
- 1997
- Team
- Over 100 scientists and researchers
Locations
- Based in
- Tainan, Taiwan
- Sites
- Changshu, China
- Serves
- Worldwide, U.S., Europe, over 100 countries
Contacts
- General enquiry
- info@scinopharm.com on their site
Public records
- FDA drug establishment registration
- 3002840477 · ANALYSIS; API MANUFACTURE; MANUFACTURE; PACK; RELABEL; REPACK source